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Abstract 
Purpose: Refractive changes in diabetic eyes have long been reported but with equivocal 
results.  The lens has been a more recent focus as the source of any change but it is 
possible that multiple sources of variation have made it difficult to demonstrate a systematic 
change clinically.  The aim of this study was therefore to use a bovine lens model to 
investigate the optical changes in hyperglycaemia and when lenses are returned to normal 
glucose levels as would occur following commencement of treatment.   
Method: Bovine eyes were obtained and their lenses excised under sterile conditions before 
placing them in culture medium within an incubator using standard tissue culture techniques.  
In the first experiment, lenses were transferred into culture medium containing 5mM (N=12), 
15mM (N=12) and 30mM (N=12) glucose. Measurements were made of the change in back 
vertex focusing distance with equatorial lens diameter using the ScanTox™ measurement 
system.  From these measurements, the back vertex focal length and primary longitudinal 
spherical aberration were derived.  In a second experiment, lenses maintained at 30mM 
glucose (N=7) were stepped down to 5mM glucose to simulate starting diabetic therapy and 
measured in the same way.  Changes over time were assessed with a linear regression 
model.    
Results: A trend towards myopia was observed with increasing hyperglycaemia, this was not 
statistically significant.  When lenses were stepped-down from hyperglycaemia to normal 
physiological levels of glucose, a hyperopic shift was observed in line with published clinical 
studies that again failed to reach statistical significance.  High variability in the measurement 
on longitudinal spherical aberration prevented any significant trends being measured.   
Conclusions: Our results suggest that there are no consistent crystalline lens-induced 
refractive changes following exposure to hyperglycaemia for time-periods up to five days 
used in the current study.  It is possible that bovine lenses are able to offset the raised 
osmotic pressure from high glucose levels in the short-term by a process of osmoregulation 
and that repeated osmotic stress or longer term exposure may be required to induce the 
changes in refraction that are seen clinically.  
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 Introduction 
 
The occurrence of transient refractive changes in diabetic patients is well documented and 
blurred vision is a common presenting symptom of diabetes mellitus. The first systematic 
analysis of refractive changes in diabetes was conducted by Duke-Elder who presented a 
case series drawn from his own practice and from the published literature.1 He concluded 
that the refractive power of the eye was directly correlated with glycaemic state with a 
tendency to myopia associated with increased blood glucose and hypermetropia with 
decreased blood glucose. Although several studies have subsequently supported Duke-
Elder’s conclusions linking acute hyperglycaemia to myopia,2-4 others have reported 
hyperopic shifts.5-7  It has been shown that the sudden reductions in blood glucose that 
occur with intensive diabetic therapy can induce significant hyperopic refractive shifts.8-10  
Hyperopia usually occurs within a few days following an abrupt decrease in plasma glucose, 
peaking at days 7-14, and regressing gradually over the subsequent four weeks.9  In 
addition to studies reporting myopic and hyperopic shifts, there are two that have reported 
no significant change in refractive status with fluctuating glucose levels.11,12  In summary, 
there is no clear evidence of a consistent refractive shift associated with glycaemic changes 
in diabetes.  
 
There are several mechanisms that could potentially explain the observed refractive 
fluctuations in diabetes.  For example, changes in axial length, corneal curvature or 
crystalline lens parameters.  Most commentators have hypothesised that alterations in lens 
thickness, shape or refractive index represent the most likely aetiology. The diabetic lens is 
prone to osmotic fluxes arising from changes to the osmolarity of the surrounding media and 
the accumulation of intracellular osmolytes, which could in turn lead to alterations in lens 
hydration and volume.13,14 However, attempts to measure geometrical changes in the lens 
during hyperglycaemia have produced mostly equivocal results.9,10,15,16  Recently Charman 
has reviewed the optical parameters that potentially explain transient refractive changes in 
diabetes.17   He concluded that parameter changes required for a clinically significant 
change in refraction were capable of being measured by modern instrumentation and 
implicated refractive index change as the mechanism to explain refraction shifts in diabetic 
eyes.  In a subsequent study the changes required in the gradient refractive index profile 
were investigated using optical modelling.18 Their results are in agreement with previous 
studies although this doesn’t rule out small multiple parameter changes, as noted by 
Charman.17 
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The human eye has varying amounts of higher order aberrations, the most significant of 
which is spherical aberration.  It has long been known that higher order aberrations can lead 
to blurred vision, a symptom often reported by diabetics.  Wiemer and co-workers have 
published the only study to our best knowledge to have reported on higher-order aberrations 
as well as biometric changes and found an increase in root mean square higher-order 
aberrations of 0.07±0.02microns.11  He considered that this was too small to affect visual 
acuity. (Average RMS higher-order aberration values in normal eyes are around 0.6micron 
for a 6mm pupil).19  Less is known therefore about higher order aberrations in diabetics but it 
is possible that subtle optical changes could be seen in the higher-order aberrations 
particularly if changes in gradient refractive index profile are implicated as noted in the 
previous paragraph. 
 
Several inter-subject variables could influence the direction and magnitude of any refractive 
change in diabetics presented with the same glucose challenge e.g. type and duration of the 
disease and degree of glucose tolerance. In an attempt to eliminate these variables the 
effect of hyperglycaemia has been investigated in normal healthy volunteers.11,20 Furishima 
and co-workers measured refractive and ocular biometric measurements in seven subjects 
in which hyperglycaemia had been induced by the administration of a standardised oral 
glucose load and an injection of Somatostatin to suppress insulin secretion.20 A consistent 
myopic shift in refraction was measured (mean -1.93D) together with an increase of lens 
thickness of 1mm within 150 minutes of the onset of hyperglycaemia. However, these results 
could not be replicated by Weimer and colleagues using the same methodology.11 In this 
study, four out of five subjects showed no change in refraction (one showed a small 
hyperopic shift) and no change in ocular geometry could be measured. 
 
An alternative approach to investigate the effect of hyperglycaemia on refractive change is to 
use an ex-vivo lens model.  Ex-vivo models allow careful control of potentially confounding 
variables and could potentially clarify the role of the lens in determining the optical properties 
of the diabetic eye.  The mammalian crystalline lens is ideal for long-term organ culture. The 
lens lacks a blood and nerve supply and can be maintained in standard cell culture 
conditions for several weeks. Bovine lenses are particularly suitable for lens research as 
they are readily available with minimal post-mortem delay 21 Although the bovine lens is 
significantly larger than its primate counterpart and has a limited accommodative range22, its 
refractive properties have been extensively investigated.23  In order to measure the optical 
properties of the lens we used a commercially available instrument, the Scan Tox™ laser 
scanning system.24 This system, which was initially developed for toxicological applications, 
is ideal for both maintaining the lens in culture, while assessing the refractive properties of 
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the lens by measuring the variation in back vertex focal length of an incident laser beam at 
several points across the diameter of the lens.  
 
The aim of this study is to investigate the effect of hyperglycaemia on the back vertex focal 
length and spherical aberration of the lens using an ex-vivo bovine lens model. Two specific 
experiments were performed: first an investigation of the optical properties of lenses 
maintained at medium and high physiological levels of glucose compared to controls and 
second, changes in the optical properties when lenses were rapidly returned to normal 
glucose levels simulating normalisation of aqueous glucose levels following the initiation of 
treatment. 
 
Materials and Methods 
 
Dissection and Bovine Lens Culture 
Following local ethical committee approval, bovine eyes from young adult animals two to 
three years old were obtained from a local abattoir within three hours post euthanasia and 
transported to the laboratory on ice. After immersion in iodine solution, the eyes were 
bisected at the equator and lenses were carefully excised under sterile conditions. The 
lenses were then placed in specially designed holders made up of an aluminium base fitted 
with a silicone rubber insert and an upper chamber of optical quality glass.  
           
The glass chamber was filled with fresh culture medium, which consisted of Medium 199, 
supplemented with Earle’s salts, 0.1 mg/L L-Glutamine, 2.2 gm/L Sodium Bicarbonate, 5.96 
gm/L HEPES, 8% FBS, 10mg/L Phenol Red and antibiotics (penicillin/streptomycin) 
(www.sigmaaldrich.com), which bathed both anterior and posterior lens surfaces. Lens 
holders were covered with a small sterile petri dish and then transferred to an incubator at 
37°C, 5% CO2 for 24 hours. At this stage, any lenses showing visible signs of mechanical 
damage or opacification were discarded and not used in subsequent experiments The 
culture medium and lens holders were prepared and maintained at all times under sterile 
conditions.  
 
Optical measurements; repeatability 
Optical measurements were made with a Scan Tox™ scanning laser system, which has 
been fully described by Dvorat and Sivak.24  A brief description is given here for 
completeness.  The scanner is designed to measure the back vertex distance at points 
across the diameter of the lens. A low power laser source (670 nm 4 mW diode) projects 
onto a plane mirror assembly inclined at 45 degrees which reflects the laser beam onto the 
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cultured lens. The mirror is mounted on a motorised carriage assembly which moves the 
mirror in 0.5mm steps under computer control allowing the laser to scan across the lens. A 
digital video camera and frame grabber produces a cross sectional image of the beam at 
each position of the mirror and the Scan Tox™ software then gives a measure of the back 
vertex distance and intensity for each beam (Figure 1).  The analysis method of the output 
from the Scan Tox™ to derive measures of back vertex focal length and higher-order 
aberrations is given in the data analysis section below. 
 
Prior to measurements, lenses were maintained overnight in M199 containing 5mM glucose.  
The lenses were then transferred to fresh medium for 30-60 minutes before being placed in 
the ScanTox laser scanning system.  Repeatability of the Scan Tox™ laser scanning system 
was assessed by measuring 3 lenses 6 times at approximately 10 minute intervals with the 
lens holder remaining in-situ in the Scan Tox™ system.   
 
Lenses maintained under hyperglycaemic conditions 
To study the effects of hyperglycaemia on the optical properties of the bovine lens, culture 
media containing varying concentrations of glucose were prepared. The culture medium for 
the control group of lenses consisted of the standard supplemented M199 medium which 
contains a physiological concentration of glucose (5mM). This medium was designated 
‘normal’ glucose. The medium representing ‘moderate’ glucose had further glucose added to 
a final concentration of 15 mM.  Medium with a glucose concentration of 30mM was 
designated ‘high’ glucose. The three experimental conditions were chosen to reflect the 
levels of glucose in normals and the range of hyperglycaemia that can occur in patients with 
diabetes  
 
Following an overnight incubation in normal glucose medium, lenses were transferred to 
fresh medium containing normal, moderate or high glucose and returned to the incubator. 
Measurements were taken with the Scan Tox™ system as described previously two to three 
times per day for five days. Media were replenished with a fresh solution at approximately 
48hr intervals. A total of 12 lenses were measured for each level of glucose. 
 
Lenses returned to normoglycaemia following hyperglycaemia 
To model the effect of starting diabetic therapy when glucose levels return to near normal 
levels rapidly, seven bovine lenses were maintained in ‘high’ glucose (30mM) culture 
medium for five days before being transferred to normal glucose medium (5mM) and 
returned to the incubator. The lenses were scanned two to three times per day for five days 
to study the change in their optical properties when the glucose level is stepped down. 
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Data Analysis 
All data handling was carried out in Excel 2007 (Microsoft Corporation, Waltham, MA). Data 
derived from the Scan Tox™  system first had unnecessary characters (brackets, comas 
etc.) removed using global research and replace commands and then the remaining 
numbers were converted from text into number format.  The maximum beam scan was fixed 
at +/- 6.25mm and the central four data points were removed as advised by developers of 
the Scan Tox™ system.  Data points were further screened to remove those affected by dust 
particles where a sudden large change in reading is occasionally evident and as additionally 
advised by the developers.  To derive values for the back vertex focal length and primary 
longitudinal spherical aberration, the individual back vertex distance measurements were 
fitted with an aberration polynomial, representing the longitudinal ray aberration L(y), of the 
following form,   42 DyCyByAyL 
    (1)      
where y is the normalised pupil coordinate (entry beam position), A is the back vertex focal 
length, B tilt, C the primary longitudinal spherical aberration and D secondary longitudinal 
spherical aberration.  This polynomial is derived from the Hamilton wavefront expansion, 
which is differentiated to obtain the transverse ray aberration, before converting to a 
longitudinal ray aberration using trigonometry.25  Equation (1) was programmed into the 
curve fitting routine in SigmaPlot 10.0 (SysStat Software Inc, Chicago, USA).  The curve 
fitting software uses a Levenberg-Marquardt minimisation routine to adjust the polynomial 
coefficients.  The routine stops when the difference on successive iterations between the 
absolute value of the norm of the residuals falls below 1e-10.  Statistical analysis was carried 
out using SPSS 19 (IBM Corp, NY, USA) and MiniTab v14 (MiniTab Inc, PA, USA). 
 
Results 
Repeatability 
The repeatability of individual data points produced by the Scan Tox™ was assessed by the 
average standard deviation of all measurement points from the three lenses tested since a 
one-way ANOVA showed no significant difference in standard deviation values between the 
lenses (P = 0.11).  The median standard deviation for each measurement point was 0.26mm 
(Interquartile range 0.14 to 0.50mm) demonstrating good repeatability for the raw data 
points.  The median value has been used since the data were slightly skewed with some 
larger values caused by possible dust particles or readings at the edge of the lens.   
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Repeatability of the fitted values for the polynomial coefficients was also assessed since 
they are the main outcome measures used in the present study.  Repeatability was high for 
back vertex focal length, A, (38.72 ± 0.24mm, 38.04 ± 0.18mm and 44.02 ± 0.22mm for the 
three lenses respectively; all values mean ± SE) and moderate for primary spherical 
aberration, C, (-12.42 ± 0.51mm, -5.74 ± 0.23mm and -2.15 ± 0.625mm for the three lenses 
respectively; all values mean ± SE).   The repeatability within lenses was generally good and 
this gave us confidence in the ability of the Scan Tox™ to discern meaningful changes in the 
back vertex focal length although we note the inter-lens variation.  Spherical aberration 
measures were much more variable with most lenses demonstrating negative spherical 
aberration but of varying magnitudes.  In part this is due to dependencies between 
polynomial coefficients and in particular the primary and secondary spherical aberration 
coefficients, which can sometimes produce large values but opposite in sign for coefficients 
C and D.   
 
Lenses maintained at normal, moderate and high glucose levels 
Figure 2 shows the average variation in back vertex distance with beam entry position for 
lenses maintained at normal (5mM), moderate (15mM) and high (30mM) glucose.  The 
measurements represent the average for 12 lenses for each glucose concentration and were 
measured at an average of 100.5 hours post immersion in the test medium (range 93 to 120 
hours).  The corresponding aberration polynomial coefficients A and C representing back 
vertex focal length and primary longitudinal spherical aberration together with their standard 
errors are shown in Table 1.  The change in the A coefficient demonstrates that back vertex 
focal length decreases with increasing glucose concentration.  This corresponds to a myopic 
shift although the confidence intervals are widely overlapping.  Primary longitudinal spherical 
aberration is much more variable and shows no similar trend. 
 
Variation in lens optical properties over time for normal, moderate and high glucose levels 
Changes in back vertex focal length (polynomial A coefficient) and primary longitudinal 
spherical aberration (C coefficient) with time were modelled using linear regression in the 
absence of any evidence of a different relationship or underlying process.  Figure 3 shows 
the distribution of linear regression coefficients of all 36 lenses tested.  Regression 
coefficients varied about zero and there was no apparent difference between the control, 
moderate and high glucose conditions.  Similar results were obtained for primary longitudinal 
spherical aberration (coefficient C, data not shown) with only six lenses having regression 
coefficients that were statistically significantly different from zero (P < 0.05). A one-way 
ANOVA with lens group as factor demonstrated that there was no statistically significant 
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difference between the lens groups for either back vertex focal length (P = 0.73) or primary 
longitudinal spherical aberration (P = 0.69). 
 
Step-down data 
Changes in back vertex focal length (polynomial A coefficient) and primary longitudinal 
spherical aberration (C coefficient) when lenses are “stepped down” from a high to a normal 
glucose medium are shown in Figure 4 along with their associated regression lines.  The 
slopes are variable and close to zero although most are positive indicating a hyperopic shift 
as the lenses are returned to normal glucose concentrations.  Table 2 presents the slopes of 
the linear regressions for each of the seven lenses.  The average regression slope for back 
vertex focal length was +0.0257 mm/h which was statistically significantly different from zero 
(P = 0.031; single sample t-test).  The average regression slope for primary spherical 
aberration was -0.0211 mm/h, which was not statistically significantly different from zero (P = 
0.67). 
 
Discussion 
 
The primary aim of the present study was to measure the effects of acute hyperglycaemia on 
the optical properties of the crystalline lens. These in-vitro conditions sought to replicate the 
environment of the lens in the early stages of diabetes mellitus where refractive fluctuations 
have been shown to occur. We know of no similar studies using near normal physiological 
levels of glucose.  Lenses that were maintained in culture medium containing normal 
physiological levels of glucose (5mM) acted as controls and were compared with lenses that 
were exposed to moderate (15mM) and high (30mM) levels of glucose for periods averaging 
100 hours. Although we identified a trend towards myopia, with the back vertex focal length 
decreasing in line with increasing glucose concentration, the differences between lens 
groups were not statistically significant. Similarly, there were no significant differences in 
primary longitudinal spherical aberration.  Equivalent studies in humans that have 
investigated the short-term effects of acute hyperglycaemia in healthy young volunteers,20,26 
and patients with newly diagnosed diabetes mellitus have similarly failed to demonstrate a 
consistent change in refractive status.3,11,16  Our results therefore indicate that even by 
controlling for some of the inherent variation in clinical studies by isolating the lens in an in 
vitro model, we have not been able to demonstrate an unambiguous and statistically 
significant change in the optical properties of the bovine lens.   
 
It is possible that inter-species differences may have accounted for the lack of response to 
increasing and decreasing glucose levels. Although the bovine lens has a similar sutural 
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system to the human lens, there are differences in fibre structure and organisation which 
may reduce its ability to undergo dynamic changes in curvature. 27 A previous morphometric 
study has shown that bovine lenses placed in solutions of widely varying tonicities (hypo and 
hypertonic) are largely refractory to osmotically-induced changes in curvature or thickness.28 
An alternative explanation is  that, as with other mammalian lenses,  the bovine lens 
possesses an efficient homeostatic mechanism to mitigate against osmotic challenge.29 
Experimental models using isolated lenses placed in anisotonic media have shown that the 
lens has an effective volume regulatory mechanism through the activation of membrane-
bound ion channels e.g. potassium chloride co-transporters, sodium potassium ATPase and 
chloride channels.13,14 A further osmotic counterbalance is provided by the organic osmolyte 
sorbitol.30,31 Intracellular sorbitol accumulation increases lens osmolarity, thereby 
establishing an osmotic gradient that favours lens hydration which may potentially offset the 
dehydration induced by acute extra-lenticular hyperglycaemia.   
Although the lens appears to be capable of maintaining its volume in the face of extreme 
shifts in tonicity, following repeated osmotic insults it is possible that these osmoregulatory 
mechanisms may become compromised. This could be further exacerbated by an increase 
in oxidative stress through depletion of the antioxidant glutathione.32,33  These oxidative 
mechanisms have been implicated in the development of diabetic cataract,29,32 which shows 
a unique damage phenotype in the outer lens cortex. The involvement of an osmotic 
mechanism in diabetic cataract formation is also implied due to the fact that tissue damage 
is preceded by swelling of lens fibres. 
 
It is also possible that inter-lens variation may have masked a small but significant change in 
BVP.  A post-hoc ANOVA was carried out on the control lenses to partition the intra and inter 
lens variation in back vertex focal length.  The pooled intra-lens standard deviation was 
±4.04mm which is higher than the values found in our repeatability measurements.  The 
reason for the higher standard deviation could well be the longer time period over which the 
lenses were measured (120 hours compared to one hour for the repeatability test).  The 
lenses were not controlled for rotational alignment and this could have added to the 
variability.  However, the value for the pooled intra-lens variation would suggest that this 
source of additional variation and other effects when placing the lenses in the ScanTox™ 
were small.  The inter-lens standard deviation is higher at ±7.34mm, which is unsurprising 
given that we can reasonably expect a range of lens powers.  Both intra and inter lens 
variation are likely to affect whether results are statistically significant or not. 
 
The impact of chronic hyperglycaemia on refractive status has been studied in populations of 
patients with type 1 diabetes mellitus. For example, a positive relationship was established in 
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a Danish population between poor glycaemic control and myopia.4 Patients with an HbA1c 
above the median value (8.8%) were found to have a 60% increased risk of a myopic shift 
compared to those who are well-controlled. Although the relationship was not linear, the 
authors suggested that there could be a threshold value of HbA1c, above which myopia is 
likely to occur.  It may also be that poor glycaemic control contributes additional stress to the 
volume regulatory channels affecting the lens over longer periods of time.  The effect of 
fluctuating glucose levels on the lens in vitro has yet to be studied. 
 
The most consistently reported relationship between plasma glucose concentration and 
refractive status is induced hyperopia following the initiation of diabetes therapy. Significant 
hyperopic shifts of a few dioptres have been reported.8-10 The hyperopia develops over a 
period of a few days to a few weeks, followed by a more gradual return to the baseline 
refraction.9 Okamoto and co-workers concluded that the magnitude of the refractive change 
depended on the pre-treatment plasma glucose concentration.8  Our results for lenses 
stepped down from 30mM to 5mM glucose show an average change in back vertex focal 
length of +0.0257mm/h correlating to just over 3mm of change for a five day period.  This is 
equivalent to an approximate 3D reduction (hyperopic shift) in back vertex power of the 
bovine lens, which is a similar order of magnitude to changes reported over the same time 
frame by.9  There has been considerable debate regarding the source of this refractive 
change.18  It is generally assumed that the thickness and curvatures of the lens remain 
unchanged and it has been hypothesised from optical modelling that the hyperopic shift is 
most likely due to a decrease in lens refractive index.18 
 
 
Conclusions 
The current study found no evidence for a consistent change in either the back focal length 
or longitudinal spherical aberration of bovine lenses at any time point in response to acute 
hyperglycaemia.  This is may be due to the ability of the lens to osmoregulate in the short-
term to offset any change in lens shape or refractive index. We identified a trend towards 
myopia with increasing hyperglycaemia, which while not statistically significant, might 
suggest that a more pronounced change could occur in the longer-term.  A trend towards 
hyperopia was also observed for lenses stepped down to normal glucose levels in line with 
clinical data supporting the argument that lens changes are the cause of refractive variation. 
The difficulties of maintaining lenses in long-term organ culture mean that the current bovine 
model may not be suitable for investigating the effect of chronic hyperglycaemia on the 
optical properties of the lens. Consequently, further work could investigate the use of lenses 
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extracted from an experimental model of diabetes e.g. streptozotocin-induced diabetes in 
rodents. 
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Figures 
 
 
Figure 1: Scanning laser profile for each refracted beam (central four beams removed – see 
text) in a control lens.  
 
Figure 2. Average back vertex distance variation for bovine lenses (N=12 each group) 
immersed in normal (green circles), moderate (blue squares) and high (red triangles) glucose 
concentrations.  Solid lines represent the respective fitted aberration polynomials.  (Error 
bars all ± 1 SE)  
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Figure 3. Distribution of linear regression coefficients for lenses at (a) normal, (b) moderate 
and (c) high glucose demonstrating the change in back vertex focal length with time. 
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Figure 4.  Variation in back vertex focal length, (a), and primary longitudinal spherical 
aberration, (b), with time for seven lenses stepped down from high to normal glucose 
concentrations (see Methods for details).  Lines represent the corresponding linear 
regression slopes. 
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Tables 
 
 
Table 1.  Fitted aberration polynomial coefficients for the average data curves shown in 
Figure 2 for lenses maintained at normal, moderate and high glucose concentrations.  (All 
values mean ± SE). 
 
Table 2.  Slope for the regression lines showing the trend in all seven lenses stepped down 
from high to normal glucose concentrations for change in back vertex focal length and 
primary longitudinal spherical aberration with time.  *indicates statistically significant at P < 
0.05.
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